What Is a Hepatologist and When Do You Need One?

A hepatologist is a physician who specializes in diseases of the liver, gallbladder, bile ducts, and pancreas. Most hepatologists are gastroenterologists who completed additional fellowship training focused specifically on the liver, making them the go-to specialists when liver problems go beyond what a primary care doctor or general gastroenterologist handles. You might need one if blood tests show unexplained liver enzyme elevations, if you’ve been diagnosed with chronic hepatitis or fatty liver disease, or if your liver has progressed toward scarring that could threaten its function. The field itself has evolved rapidly over roughly 75 years, driven by breakthroughs in antiviral therapy, transplantation, and our understanding of genetic contributors to liver disease.

How Hepatologists Differ From Gastroenterologists

Gastroenterologists cover the entire digestive tract, from the esophagus to the colon. Hepatologists narrow that focus to the liver and its connected plumbing. Think of it as the difference between a cardiologist who handles all heart conditions and an electrophysiologist who concentrates on rhythm disorders. Both are qualified internists with gastroenterology training, but the hepatologist has spent extra time learning the nuances of liver pathology, transplant medicine, and the complex metabolic work the liver performs.

This distinction matters in practice. A general gastroenterologist comfortably manages straightforward cases of fatty liver or monitors someone with well-controlled hepatitis B. But when disease progresses, when liver scarring advances, when a transplant evaluation enters the picture, or when a rare autoimmune condition is suspected, a hepatologist’s deeper training makes a measurable difference. Research on hepatocellular carcinoma management, for example, identifies hepatologists as ideal providers to guide care because they are trained to identify at-risk patients, apply surveillance strategies, assess residual liver function, evaluate transplant candidacy, and manage decompensating events over the long term.¹

When Your Doctor Should Refer You

The most common trigger is abnormal liver blood tests that your primary care doctor can’t explain. Elevated liver enzymes (ALT and AST), high bilirubin, or abnormal alkaline phosphatase can signal anything from a medication side effect to a serious underlying disease. British clinical guidelines recommend that adults with persistently abnormal liver blood tests, even after extended screening comes back negative and no obvious risk factors are identified, should be referred to a gastroenterologist with liver expertise or a hepatologist for further evaluation.² In other words, if basic investigations don’t explain what’s going on, a liver specialist should take a look.

Beyond unexplained labs, your doctor may refer you if you have:

Chronic viral hepatitis: hepatitis B or C that requires long-term monitoring or antiviral treatment
Metabolic liver disease: fatty liver that has progressed to inflammation or fibrosis
Alcohol-related liver damage: especially if cirrhosis or severe alcoholic hepatitis is suspected
Autoimmune conditions: diseases like primary biliary cholangitis or autoimmune hepatitis
Suspected drug-induced liver injury: when a medication, supplement, or herbal product appears to be damaging your liver
Signs of advanced scarring: fluid buildup in the abdomen, confusion, jaundice, or bleeding from enlarged veins in the esophagus

Timing matters. A multi-center study within the VA health system found that patients evaluated within 30 days of referral for liver transplant had better outcomes, underscoring that delays in getting to a specialist can have real consequences when liver disease is advanced.³

The Major Conditions Hepatologists Treat

Metabolic Fatty Liver Disease

This is arguably the most common reason people end up in a hepatologist’s office today. Metabolic dysfunction-associated steatotic liver disease (the current name for what was previously called nonalcoholic fatty liver disease) affects a huge slice of the adult population. Most people with fatty liver never develop serious problems, but a subset progress to inflammation, scarring, and eventually cirrhosis. A hepatologist coordinates a multidisciplinary approach, recognizing that this condition sits at the center of a cardiovascular-liver-metabolic syndrome. Several drugs used to treat related conditions like diabetes and high cholesterol show potential in slowing liver disease progression, and some have demonstrated benefits on liver tissue changes that are expected to translate into long-term improvements.⁴

Viral Hepatitis

Hepatitis B and hepatitis C remain major drivers of chronic liver disease worldwide. Hepatitis C is now curable in most patients with direct-acting antiviral medications, but someone still needs to manage the treatment, monitor for drug interactions, and check whether any liver damage persists afterward. Hepatitis B is trickier because it’s rarely cured outright. The American Association for the Study of Liver Diseases (AASLD) provides detailed guidelines for screening, monitoring, and treating chronic hepatitis B, including specific recommendations for different patient groups such as those who haven’t been treated before, those with compensated or decompensated cirrhosis, and people with drug resistance or coinfections.⁵ Managing these patients requires sustained attention to viral load, liver function, and cancer screening, which is squarely in a hepatologist’s wheelhouse.

Alcohol-Related Liver Disease

Alcohol-related liver disease spans a spectrum from simple fatty changes to severe alcoholic hepatitis and cirrhosis. Severe alcoholic hepatitis, defined by a Model for End-Stage Liver Disease (MELD) score above 20, carries a grim prognosis and can progress to multi-organ failure. Corticosteroid therapy improves one-month survival from roughly 65% to 80% in appropriate patients, but this is one area where the evidence remains limited and the decisions complex.⁶ Current guidelines emphasize that patients with alcohol-related liver disease are rarely treated for their underlying alcohol use disorder, and advocate for integrated care models that bring together hepatology, addiction medicine, and social work to address both the liver damage and the drinking.⁷ Liver transplantation can be appropriate for selected patients with severe alcoholic hepatitis who don’t respond to medical treatment and are judged to have a low risk of returning to alcohol use after surgery.

Autoimmune and Rare Liver Diseases

Conditions like primary biliary cholangitis (PBC) and autoimmune hepatitis are uncommon enough that many general practitioners and even general gastroenterologists see very few cases in their careers. This is where a hepatologist’s focused expertise becomes especially valuable. PBC, for instance, can progress quickly, with some patients advancing through histological stages as rapidly as every two years. Up to 30% of patients develop a severe, progressive form that leads to early liver fibrosis and liver failure.⁸ Early diagnosis and treatment are essential, and a hepatologist is best positioned to make that happen.

How Liver Disease Is Diagnosed and Staged

One of the first things a hepatologist will want to know is how much scarring (fibrosis) your liver has developed. This information drives nearly every treatment decision. For decades, liver biopsy was the only reliable way to assess fibrosis. It’s still considered the gold standard, but it’s invasive, carries a small risk of bleeding, and samples only a tiny fraction of the organ. Non-invasive alternatives have changed the landscape considerably.

Transient elastography, commonly known by the brand name FibroScan, uses ultrasound-based technology to measure liver stiffness, which correlates with the degree of scarring. A meta-analysis found that this technique has excellent diagnostic accuracy for identifying cirrhosis and advanced fibrosis (stage 3 and above), and its accuracy improves as the degree of scarring increases.⁹ A separate systematic review concluded that transient elastography can serve as a viable alternative to biopsy in fatty liver disease patients and plays a particularly strong role in ruling out cirrhosis.¹⁰

That said, these tools aren’t perfect. A study looking at FibroScan’s ability to identify advanced fibrosis in patients with metabolic fatty liver disease found that it correctly flagged only about 46% of patients who actually had biopsy-confirmed advanced scarring, while blood-based scoring systems performed even worse.¹¹ This means that a hepatologist still uses clinical judgment alongside these tests. A normal FibroScan result in someone with multiple risk factors might prompt a biopsy anyway, while a clearly elevated reading in an otherwise straightforward case might be enough to guide treatment without one.

Managing Cirrhosis and Its Complications

When liver disease progresses to cirrhosis, the hepatologist becomes something closer to a long-term care coordinator. Cirrhosis can lead to a cascade of complications including fluid buildup in the abdomen (ascites), enlarged veins in the esophagus that can bleed dangerously (varices), confusion from toxin buildup in the brain (hepatic encephalopathy), liver cancer, and clotting problems.¹² Each of these requires its own monitoring and management strategy, and they frequently overlap.

What makes cirrhosis management particularly challenging is that the liver affects so many other organ systems. Poor liver function disrupts how your body processes medications, handles infections, maintains blood pressure, and even breathes. Hepatologists manage these interconnected problems and decide when it’s time to escalate to a transplant discussion. For patients who aren’t transplant candidates, the focus shifts to preventing acute crises and maintaining the best possible quality of life.

Cancer Surveillance in High-Risk Patients

People with cirrhosis, chronic hepatitis B, or certain other liver conditions carry an elevated risk of developing hepatocellular carcinoma, the most common type of primary liver cancer. Hepatologists typically recommend ultrasound screening every six months for these patients, sometimes combined with a blood test for alpha-fetoprotein. The goal is to catch tumors when they’re small enough to be treated curatively, whether through surgery, ablation, or transplantation.

Hepatologists are considered particularly well suited for this role because they manage patients longitudinally. They already know the patient’s liver function, their disease trajectory, and their treatment history. When a suspicious lesion appears, the hepatologist can rapidly assess whether the patient is a candidate for transplant, whether their liver can tolerate a surgical procedure, and how to preserve liver function during and after cancer treatment.¹ This continuity of care distinguishes the hepatologist’s approach from that of an oncologist who might meet the patient only after a cancer diagnosis.

Drug-Induced Liver Injury

Your liver processes virtually everything you swallow, inject, or absorb, and sometimes that processing goes wrong. Drug-induced liver injury can be triggered by prescription medications, over-the-counter painkillers, herbal supplements, and even dietary products marketed as “natural.” The key to limiting damage is recognizing the problem early and stopping the offending agent as quickly as possible.¹³

In mild cases, the liver recovers on its own once the culprit is removed. In severe cases, drug-induced injury can progress to acute liver failure, which requires intensive care and occasionally an emergency transplant. Patients with any degree of mental confusion from liver failure typically need ICU-level monitoring.¹⁴ Integrated referral networks have noted a significant increase in acute liver injury from drugs, herbals, and supplements in recent years, reflecting a growing problem that hepatologists are increasingly called upon to manage.¹⁵

The Liver Transplant Pathway

For people with end-stage liver disease or certain liver cancers, transplantation is the definitive treatment. Hepatologists are central to this process from start to finish. During the initial evaluation, the team conducts a detailed review of the patient’s liver disease history, other medical conditions, social support, and substance use history. Patients receive counseling about the listing process, waiting times, MELD scores (which determine priority on the transplant list), the surgical procedure, anti-rejection medications, and expected outcomes after transplant.³

After transplantation, the hepatologist continues managing the patient, monitoring for organ rejection, drug side effects, disease recurrence, and the long-term health complications that come with immunosuppression. This post-transplant role can last for the rest of the patient’s life.

What to Expect at Your First Appointment

If you’ve been referred to a hepatologist, a few things will help you get the most out of the visit. Bring a complete list of every medication, supplement, vitamin, and herbal product you take. The liver processes all of these, and any one of them could be contributing to abnormal test results. Be prepared with previous lab work, imaging results, and any pathology reports if a biopsy has already been done.

Expect detailed questions about alcohol use. Research shows that the quality of alcohol histories taken before patients reach a hepatologist is often poor. One study found that only about 17% of referral letters to a liver clinic contained an informative alcohol history, despite roughly a third of patients later disclosing risky alcohol consumption during their initial hepatology consultation.¹⁶ Hepatologists are trained to ask these questions without judgment because alcohol use directly affects treatment planning, medication choices, and transplant eligibility. Being honest saves time and leads to better care.

The hepatologist will likely order additional blood work and may schedule imaging or elastography. Depending on the complexity of your case, the first appointment may result in a diagnosis and treatment plan, or it may be the beginning of a workup that takes several visits to complete. Conditions like autoimmune hepatitis sometimes require a biopsy before a definitive diagnosis can be made.

The Role of Nutrition and Multidisciplinary Teams

Liver disease doesn’t happen in isolation from the rest of the body, and managing it well often requires more than one specialist. AASLD practice guidance emphasizes that multidisciplinary care involving hepatologists, registered dietitians, physical therapists, and other specialists is critical for patients with cirrhosis. Malnutrition, muscle wasting, and frailty are remarkably common in advanced liver disease, and nutritional support combined with individualized exercise programs should be woven into routine clinical care.¹⁷

For patients with alcohol-related liver disease, this team often expands to include addiction medicine specialists and social workers, because treating the liver without addressing the underlying drinking problem is unlikely to succeed in the long run. For patients with metabolic fatty liver disease, endocrinologists and cardiologists may join the care team, since diabetes, obesity, and cardiovascular risk are all tangled up with the liver condition. The hepatologist acts as the hub connecting these spokes.

Access Challenges and Getting to a Specialist

One of the frustrating realities of hepatology care is that it’s concentrated in urban academic medical centers, leaving large parts of the country underserved. Research examining counties across the United States found that areas with low access to liver disease specialty care had higher rates of liver-related death, with the worst outcomes in areas both far from a transplant center and without a local gastroenterologist. These same counties tended to be more rural, have higher poverty rates, and have less access to the devices and broadband internet speeds that telehealth requires.¹⁸

Telehealth has been proposed as a solution, and it does help bridge the gap for some patients. But the research suggests that a strategy relying solely on patients owning devices with reliable internet would exclude many of the people who need care the most. Hub-and-spoke referral networks, where smaller hospitals partner with larger transplant centers, represent one alternative. Studies of these networks show that they successfully funnel patients with end-stage liver disease and acute liver injury toward appropriate specialty evaluation, even when the patient’s local hospital lacks a hepatologist on staff.¹⁵ If you live in a rural area and suspect you need liver specialty care, asking your primary care doctor about these referral arrangements is a reasonable first step, even if no hepatologist practices nearby.

1
PubMed Central. Holistic management of hepatocellular carcinoma: The hepatologist’s comprehensive playbook
2
PubMed Central. Guidelines on the management of abnormal liver blood tests
3
PubMed Central. Evaluation Within Thirty Days of Referral for Liver Transplantation is Associated with Reduced Mortality: A Multi-Center Analysis of Patients Referred Within the VA Health System
4
PubMed Central. Therapeutic management of metabolic dysfunction associated steatotic liver disease
5
PubMed Central. AASLD guidelines for treatment of chronic hepatitis B
6
JAMA. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review
7
PubMed Central. ACG Clinical Guideline: Alcohol-Associated Liver Disease
8
American Journal of Gastroenterology. Diagnosis and Management of Primary Biliary Cholangitis
9
PubMed Central. Diagnostic Accuracy of Elastography and Liver Disease: A Meta-Analysis
10
PubMed Central. Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
11
PubMed Central. The accuracy of FibroScan, FIB-4, and nonalcoholic fatty liver disease fibrosis score in predicting biopsy-defined fibrosis and steatosis across all fibrosis stages in patients with metabolic dysfunction associated steatotic liver disease
12
PubMed Central. Cirrhosis and its complications: evidence based treatment
13
PubMed Central. Drug-induced Liver Injury
14
PubMed Central. Drug-induced Acute Liver Failure
15
PubMed Central. The role of an integrated referral program for patients with liver disease: A network between hub and spoke centers
16
PubMed Central. Assessment of alcohol histories obtained from patients with liver disease: opportunities to improve early intervention
17
PubMed Central. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
18
PubMed Central. Access to technology to support telehealth in areas without specialty care for liver disease